J. C. Nelson All authors

Coronavirus disease 2019 (COVID-19) vaccination and stillbirth in the Vaccine Safety Datalink.

Obstetrics and Gynecology. 2024

3 Total citations

3 Recent citations

Impact of the COVID-19 pandemic on health care utilization in the Vaccine Safety Datalink: retrospective cohort study.

JMIR public health and surveillance. 2024

3 Total citations

3 Recent citations

Influenza vaccination accuracy among adults: self-report compared with electronic health record data.

Vaccine. 2024

2 Total citations

Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection.

Nature communications. 2024

13 Total citations

13 Recent citations

Safety of the seasonal influenza vaccine in 2 successive pregnancies.

JAMA network open. 2024

2 Total citations

Tinnitus after COVID-19 vaccination: findings from the vaccine adverse event reporting system and the vaccine safety datalink.

American Journal of Otolaryngology. 2024

1 Total citation

7.63 Field Citation Ratio

A broad assessment of COVID-19 vaccine safety using tree-based data-mining in the vaccine safety datalink.

Vaccine. 2023

14 Total citations

13 Recent citations

1.13 Relative Citation Ratio

Active postlicensure safety surveillance for recombinant zoster vaccine using electronic health record data.

American Journal of Epidemiology. 2023

11 Total citations

11 Recent citations

5.84 Field Citation Ratio

2.93 Relative Citation Ratio

COVID-19 booster vaccination in early pregnancy and surveillance for spontaneous abortion.

JAMA network open. 2023

13 Total citations

13 Recent citations

14 Field Citation Ratio

1.98 Relative Citation Ratio

COVID-19 vaccine safety surveillance in early pregnancy in the United States: design factors affecting the association between vaccine and spontaneous abortion.

American Journal of Epidemiology. 2023

4 Total citations

4 Recent citations

2.06 Field Citation Ratio

0.73 Relative Citation Ratio

Medically attended acute adverse events in pregnant people after coronavirus disease 2019 (COVID-19) booster vaccination.

Obstetrics and Gynecology. 2023

6 Total citations

6 Recent citations

6.84 Field Citation Ratio

1.04 Relative Citation Ratio

Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: the contribution of vaccine-related attitudes.

Preventive Medicine. 2023

2 Total citations

1.19 Field Citation Ratio

1.07 Relative Citation Ratio

Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink.

Vaccine. 2023

6 Total citations

6 Recent citations

5.48 Field Citation Ratio

0.97 Relative Citation Ratio

Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink.

Vaccine. 2023

3 Total citations

3 Recent citations

1.16 Field Citation Ratio

1.12 Relative Citation Ratio

Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic.

Vaccine. 2022

11 Total citations

10 Recent citations

5.84 Field Citation Ratio

1.02 Relative Citation Ratio

Evaluation of acute adverse events after Covid-19 vaccination during pregnancy.

New England Journal of Medicine. 2022

42 Total citations

37 Recent citations

28 Field Citation Ratio

2.72 Relative Citation Ratio

Health care utilization in the 6 months following SARS-CoV-2 infection.

JAMA network open. 2022

41 Total citations

40 Recent citations

21 Field Citation Ratio

3.69 Relative Citation Ratio

Incidence of Guillain-Barré syndrome after COVID-19 vaccination in the Vaccine Safety Datalink.

JAMA network open. 2022

124

124 Total citations

90 Recent citations

65 Field Citation Ratio

10 Relative Citation Ratio

Kawasaki disease following the 13-valent pneumococcal conjugate vaccine and rotavirus vaccines.

Pediatrics. 2022

6 Total citations

6 Recent citations

3.18 Field Citation Ratio

0.59 Relative Citation Ratio

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.

Vaccine. 2022

53 Total citations

40 Recent citations

28 Field Citation Ratio

2.61 Relative Citation Ratio

Safety of COVID-19 vaccination in United States children ages 5 to 11 years.

Pediatrics. 2022

47 Total citations

32 Recent citations

24 Field Citation Ratio

2.7 Relative Citation Ratio

COVID-19 vaccination coverage among insured persons aged ≥16 years, by race/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021.

MMWR: Morbidity and Mortality Weekly Report. 2021

41 Total citations

20 Recent citations

10 Field Citation Ratio

2.13 Relative Citation Ratio

COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021.

MMWR: Morbidity and Mortality Weekly Report. 2021

181

181 Total citations

87 Recent citations

87 Field Citation Ratio

13 Relative Citation Ratio

Surveillance for adverse events after COVID-19 mRNA vaccination.

JAMA. 2021

540

540 Total citations

245 Recent citations

191 Field Citation Ratio

32 Relative Citation Ratio

Challenges involved in establishing a web-based clinical decision support tool in community health centers.

Healthcare (Amsterdam, Netherlands). 2020

9 Total citations

7 Recent citations

2.59 Field Citation Ratio

0.6 Relative Citation Ratio

Evaluating the association of stillbirths after maternal vaccination in the Vaccine Safety Datalink.

Obstetrics and Gynecology. 2020

19 Total citations

12 Recent citations

6.92 Field Citation Ratio

0.7 Relative Citation Ratio

Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents.

Pharmacoepidemiology and Drug Safety. 2018

7 Total citations

1.85 Field Citation Ratio

0.26 Relative Citation Ratio

Development and validation of a method to identify children with social complexity risk factors.

Pediatrics. 2016

16 Total citations

3.37 Field Citation Ratio

0.87 Relative Citation Ratio

Safety of measles-containing vaccines in 1-year-old children.

Pediatrics. 2015

44 Total citations

8 Recent citations

8.48 Field Citation Ratio

1.43 Relative Citation Ratio

Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.

Vaccine. 2014

37 Total citations

7.19 Field Citation Ratio

1.11 Relative Citation Ratio

Timely versus delayed early childhood vaccination and seizures.

Pediatrics. 2014

43 Total citations

1.5 Relative Citation Ratio

10 Field Citation Ratio

A population-based cohort study of undervaccination in 8 managed care organizations across the United States.

JAMA pediatrics. 2013

149

149 Total citations

11 Recent citations

29 Field Citation Ratio

5.08 Relative Citation Ratio

Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age.

JAMA pediatrics. 2013

75 Total citations

10 Recent citations

14 Field Citation Ratio

2.47 Relative Citation Ratio

Vaccination site and risk of local reactions in children 1 through 6 years of age.

Pediatrics. 2013

24 Total citations

4.75 Field Citation Ratio

0.83 Relative Citation Ratio

Injection site and risk of medically attended local reactions to acellular pertussis vaccine.

Pediatrics. 2011

24 Total citations

0 Recent citations

4.3 Field Citation Ratio

0.85 Relative Citation Ratio

Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study.

BMC Infectious Diseases. 2009

24 Total citations

4.36 Field Citation Ratio

0.68 Relative Citation Ratio

Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study.

Vaccine. 2009

31 Total citations